Avacta Group Plc, listed on the London Stock Exchange under the ticker LON: AVCT, is a UK-based biotechnology company focusing on cancer therapeutics and diagnostics. The company operates through two major divisions: Therapeutics and Diagnostics, utilizing its proprietary technologies—Affimer and pre|CISION—to develop solutions that address critical healthcare challenges, such as cancer and autoimmune diseases. The […]